Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jun 20;381(6584):713-6.
doi: 10.1038/381713a0.

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

Affiliations

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

T Waldman et al. Nature. .

Abstract

Precise coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells. Here we show that p21 WAF1/CIP1, the prototype inhibitor of cyclin-dependent kinases (CDKs), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.

PubMed Disclaimer

Comment in

  • Cell-cycle control and its watchman.
    Jacks T, Weinberg RA. Jacks T, et al. Nature. 1996 Jun 20;381(6584):643-4. doi: 10.1038/381643a0. Nature. 1996. PMID: 8649505 No abstract available.
  • p53 and treatment of bladder cancer.
    Cote RJ, Esrig D, Groshen S, Jones PA, Skinner DG. Cote RJ, et al. Nature. 1997 Jan 9;385(6612):123-5. doi: 10.1038/385123b0. Nature. 1997. PMID: 8990112 Clinical Trial. No abstract available.

Similar articles

Cited by

Publication types

LinkOut - more resources